Hepatitis C
Michael Banks, MD, on Relaxed Criteria for Medicaid Program Increases DAA Treatment Use in HCV
08/24/2018
Michael Banks, MD, talks about how 2016 Medicaid criteria has allowed for increased access to direct-acting antiviral therapies among patients with hepatitis C virus for whom the costs of the treatments were too high.
For more videos, visit our partners at The Doctor's Channel.